BRIEF published on 04/30/2024 at 18:20, 2 years 1 month ago EUROPLASMA announces the postponement of the publication of the 2023 financial statements Financial Results Europlasma Postponed Publication Financial Statements 2023 Acquisition MG-Valdunes
BRIEF published on 04/24/2024 at 18:05, 2 years 1 month ago EUROPLASMA launches significant bond financing to support its growth Shareholder Dilution Europlasma Environment Railway Industry Bond Financing
BRIEF published on 04/19/2024 at 18:05, 2 years 1 month ago EUROPLASMA announces the drawing of the fourteenth tranche of its bond issue Investment Europlasma OCEANE Financial Risk Dilution Of Capital
BRIEF published on 04/17/2024 at 18:05, 2 years 1 month ago EUROPLASMA and Adomos end their exclusive discussions without final agreement Europlasma Negotiations Discussions Adomos Reconciliation
BRIEF published on 04/10/2024 at 07:35, 2 years 1 month ago EUROPLASMA announces a reverse stock split on Euronext Growth Europlasma Euronext Growth Dépollution Consolidation Of Actions Material Recovery
BRIEF published on 04/04/2024 at 16:23, 2 years 1 month ago EUROPLASMA publishes its total voting rights and shares as of March 31, 2024 Voting Rights Capital Europlasma Regulation Financial Markets
BRIEF published on 03/29/2024 at 11:35, 2 years 2 months ago EUROPLASMA announces a reduction of its capital to compensate for its losses Board Of Directors Europlasma Dépollution Capital Reduction General Assembly
BRIEF published on 03/20/2024 at 18:05, 2 years 2 months ago Validation by the Lille Court of the takeover offer of MG-Valdunes by Europlasma Europlasma MG-Valdunes Energetic Transition Railway Industry The Commercial Court
BRIEF published on 03/12/2024 at 18:05, 2 years 2 months ago EUROPLASMA announces the drawing of a new tranche of OCEANE for one million euros Europlasma OCEANE Dilution Bond Loan Waste Recovery
BRIEF published on 03/05/2024 at 14:13, 2 years 2 months ago EUROPLASMA announces its total number of voting rights and shares as of February 29, 2024 Voting Rights Capital Actions Europlasma Financial Markets
Published on 05/30/2026 at 04:00, 2 days ago Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 2 days 1 hour ago BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 2 days 2 hours ago Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 2 days 3 hours ago Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 2 days 5 hours ago The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 05/31/2026 at 00:15, 1 day 3 hours ago Take Your Shot & Make Your Moment: OPPO Ignites Football Culture with Technology at the UEFA Champions League Final
Published on 05/30/2026 at 19:35, 1 day 8 hours ago THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Published on 05/30/2026 at 17:10, 1 day 10 hours ago MakerWorld's First User-Initiated Charity Contest Names Winners, Bringing Global Creators' Goodwill Directly to Cancer Wards
Published on 05/29/2026 at 21:42, 2 days 6 hours ago EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 2 days 6 hours ago Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 22:00, 2 days 6 hours ago Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 2 days 10 hours ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 12:00, 2 days 16 hours ago Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 2 days 17 hours ago bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market
